Impact of Vascular Access Route and Drug Presentation on Epinephrine Administration Time: A Pilot Study in Clinical Simulation
试验速览
- 阶段
- 不适用
- 状态
- Enrolling By Invitation
- 入组人数
- 52
- 试验地点
- 1
- 主要终点
- Total Time for Epinephrine Administration.
研究概览
简要总结
Rapid administration of epinephrine is an essential component of advanced life support during cardiac arrest. Peripheral intravenous (IV) access is commonly used for drug delivery, while intraosseous (IO) access is an alternative when IV access is not readily available. In addition, epinephrine may be administered using different drug presentations, such as ampoules or prefilled syringes, which may influence procedural workflow during resuscitation.
详细描述
Out-of-hospital cardiac arrest (OHCA) is a time-critical emergency that requires rapid and coordinated interventions by healthcare professionals. Advanced life support protocols emphasize high-quality cardiopulmonary resuscitation, minimization of interruptions, and timely administration of vasoactive medications such as epinephrine in non-shockable rhythms.
Peripheral intravenous (IV) access is frequently used as the initial route for drug administration during cardiac arrest, while intraosseous (IO) access is incorporated into resuscitation algorithms as an alternative when IV access is difficult or delayed. The practical implementation of these access routes may vary depending on operator experience, technical complexity, and clinical context.
In addition to the choice of vascular access, the presentation of emergency medications may affect procedural performance during resuscitation. Epinephrine can be prepared from ampoules or administered using prefilled syringes, each involving different handling steps during emergency care. Evaluating procedural timing across these variables in a controlled environment may provide information relevant to training and workflow optimization.
The purpose of this study is to evaluate the time required to administer 1 mg of epinephrine and the total procedure time according to the vascular access route (IV versus IO) and the drug presentation (ampoule versus prefilled syringe) in a simulated cardiac arrest setting.
Participants will be fourth-year nursing students enrolled during the 2023-2024 academic year. Participation will be voluntary. All participants will receive standardized theoretical and practical training before taking part in the simulation scenarios.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •4th year Nursing students
排除标准
- •1-2-3 th year Nursing students
研究组 & 干预措施
IV + Ampoule
Participants perform intravenous (IV) access and administer epinephrine using a standard glass ampoule.
干预措施: Epinephrine Ampoule (Manual Preparation) (Device)
IV + Ampoule
Participants perform intravenous (IV) access and administer epinephrine using a standard glass ampoule.
干预措施: Intravenous (IV) Access (Other)
IV + Prefilled Syringe
Participants perform intravenous (IV) access and administer epinephrine using a prefilled syringe.
干预措施: Epinephrine Prefilled Syringe (Ready-to-use) (Device)
IV + Prefilled Syringe
Participants perform intravenous (IV) access and administer epinephrine using a prefilled syringe.
干预措施: Intravenous (IV) Access (Other)
IO + Ampoule
Participants perform intraosseous (IO) access and administer epinephrine using a standard glass ampoule.
干预措施: Epinephrine Ampoule (Manual Preparation) (Device)
IO + Ampoule
Participants perform intraosseous (IO) access and administer epinephrine using a standard glass ampoule.
干预措施: Intraosseous (IO) Access Device (Device)
IO + Prefilled Syringe
Participants perform intraosseous (IO) access and administer epinephrine using a prefilled syringe.
干预措施: Epinephrine Prefilled Syringe (Ready-to-use) (Device)
IO + Prefilled Syringe
Participants perform intraosseous (IO) access and administer epinephrine using a prefilled syringe.
干预措施: Intraosseous (IO) Access Device (Device)
结局指标
主要结局
Total Time for Epinephrine Administration.
时间窗: During the simulation procedure (Day 1)
The interval of time (in seconds) from the instruction to begin the procedure until the complete administration of 1 mg of epinephrine into the simulation device.
次要结局
- Time to Successful Vascular Access (Cannulation Time)(During the simulation procedure (Day 1))
研究者
María del Carmen Casal Angulo
Associate Professor of Nursing
University of Valencia
